InvestSMART

Argenica Therapeutics Limited (ASX: AGN) - Announcements

- Current share price for AGN : $0.175

ASX company news and announcements for Argenica Therapeutics Limited (AGN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Argenica Therapeutics Limited (AGN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Argenica Therapeutics Limited (AGN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Argenica Therapeutics Limited (AGN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$22 Board Update 27 Oct 2023 11:43AM $0.340 $0.175 fallen by 48.53%
$22 Notice of Annual General Meeting/Proxy Form 27 Oct 2023 11:37AM $0.335 $0.175 fallen by 47.76%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 26 Oct 2023 8:17AM $0.340 $0.175 fallen by 48.53%
$22 Investor Presentation 25 Oct 2023 11:26AM $0.340 $0.175 fallen by 48.53%
$22 Preclinical HIE Study - ARG007 Effective Stand-Alone Therapy 18 Oct 2023 8:19AM $0.340 $0.175 fallen by 48.53%
$22 Date of AGM & Closing Date For Director Nominations 29 Sep 2023 4:45PM $0.375 $0.175 fallen by 53.33%
$22 Ethics Approval Received for Phase 2 Trial 12 Sep 2023 9:16AM $0.385 $0.175 fallen by 54.55%
$22 Grant Awarded To Develop Additional Administration Route 12 Sep 2023 9:13AM $0.385 $0.175 fallen by 54.55%
$22 Presentation - Fetal and Neonatal Scientific Conference 4 Sep 2023 9:48AM $0.380 $0.175 fallen by 53.95%
$22 Presentation - Stroke 2023 Scientific Conference 24 Aug 2023 9:40AM $0.430 $0.175 fallen by 59.30%
$22 Positive FDA Feedback Following Pre-Ind Meeting 23 Aug 2023 8:46AM $0.380 $0.175 fallen by 53.95%
$22 Appendix 4G & Corporate Governance Statement 23 Aug 2023 8:34AM $0.380 $0.175 fallen by 53.95%
$22 Appendix 4E & Annual Report 30 June 2023 23 Aug 2023 8:33AM $0.380 $0.175 fallen by 53.95%
$22 Response to ASX Aware Query 18 Aug 2023 11:33AM $0.380 $0.175 fallen by 53.95%
$22 Cleansing Notice 3 Aug 2023 11:31AM $0.390 $0.175 fallen by 55.13%
$22 Application for quotation of securities - AGN 3 Aug 2023 11:29AM $0.390 $0.175 fallen by 55.13%
$22 ARG-007 Prevents Uptake & Aggregation of Key Protein 1 Aug 2023 9:01AM $0.365 $0.175 fallen by 52.05%
$22 Investor Presentation 25 Jul 2023 9:27AM $0.370 $0.175 fallen by 52.70%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 24 Jul 2023 9:04AM $0.380 $0.175 fallen by 53.95%
$22 ARG-007 Phase 2 Clinical Trial Update 19 Jul 2023 8:23AM $0.375 $0.175 fallen by 53.33%
$22 Ceasing to be a substantial holder 17 Jul 2023 8:15AM $0.345 $0.175 fallen by 49.28%
$22 ARG-007 Protects Brain Cells in Moderate TBI Model 22 Jun 2023 8:19AM $0.360 $0.175 fallen by 51.39%
$22 Becoming a substantial holder 20 Jun 2023 8:21AM $0.380 $0.175 fallen by 53.95%
$22 Becoming a substantial holder 13 Jun 2023 5:34PM $0.370 $0.175 fallen by 52.70%
$22 Application for quotation of securities - AGN 13 Jun 2023 9:33AM $0.390 $0.175 fallen by 55.13%

151 - 175 of 291 results

Page 7 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.